Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in Interest ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

Nuvation Bio (NUVB-WT) Depreciation & Amortization (CF) (2023 - 2025)

Nuvation Bio (NUVB-WT) has disclosed Depreciation & Amortization (CF) for 3 consecutive years, with $539000.0 as the latest value for Q4 2025.

  • Quarterly Depreciation & Amortization (CF) rose 146.12% to $539000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.7 million through Dec 2025, up 154.61% year-over-year, with the annual reading at $1.7 million for FY2025, 154.61% up from the prior year.
  • Depreciation & Amortization (CF) for Q4 2025 was $539000.0 at Nuvation Bio, up from $534000.0 in the prior quarter.
  • The five-year high for Depreciation & Amortization (CF) was $539000.0 in Q4 2025, with the low at $55000.0 in Q3 2023.
  • Average Depreciation & Amortization (CF) over 3 years is $220333.3, with a median of $190500.0 recorded in 2024.
  • The sharpest move saw Depreciation & Amortization (CF) grew 3.57% in 2024, then surged 434.48% in 2025.
  • Over 3 years, Depreciation & Amortization (CF) stood at $55000.0 in 2023, then surged by 298.18% to $219000.0 in 2024, then surged by 146.12% to $539000.0 in 2025.
  • According to Business Quant data, Depreciation & Amortization (CF) over the past three periods came in at $539000.0, $534000.0, and $356000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.